BIOCON a rating raised
as of Wed 28 Jan 15:30
BIOCON LIMITED. filed a rating raised of S&P Global BB+ on Wed 28 Jan 2026.
Its size: 1 notch.
Where it came from
as of Wed 28 Jan 15:30
Sources
- Filed
- NSE · 2026-01-28 08:46 IST
- Document
raw/nse_announcement_docs/2026-01-28/5c6e2d5e223d_5c6e2d5e223d_BIOCON_28012026084529_Pressrelease28012026.pdf· SHA-256 5c6e2d5e223d- Read from
- “S&P Global Upgrades Biocon Biologics Credit Rating To ‘BB+’ Revises Outlook to “Stable”” · page 1 · characters 654–744
- Read by
- claude-sonnet-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed
- Measured against
- the steps of the rating scale · as of 28 Jan 2026
- Kind
- credit rating action
What such filings have been followed by
as of Wed 28 Jan 15:30
| Over | In | Beyond its normal day | Beyond what options priced |
|---|---|---|---|
| This stock | the next session | 0 of 1 | 1 of 1 |
| This stock | the next five sessions | 0 of 1 | 0 of 1 |
| Its industry (Healthcare) | the next session | 2 of 7 | 5 of 6 |
| Its industry (Healthcare) | the next five sessions | 0 of 6 | 3 of 5 |
| Every stock | the next session | 34 of 197 | 92 of 196 |
| Every stock | the next five sessions | 27 of 195 | 91 of 190 |
Counts of past filings of the same kind and size: of how many, how many were followed by a move bigger than the stock's own normal day, and bigger than what its options priced for the same span. A greyed row has fewer than 30 cases, too few to read as a tendency, and its counts are printed anyway. A filing whose sessions have not all arrived is not counted.